<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 22 Oct 2026 07:41:41 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>DataMEDS AI signs amended LOI to acquire drone and blockchain health IP</title>
   <link>http://www.streetinsider.com/Corporate+News/DataMEDS+AI+signs+amended+LOI+to+acquire+drone+and+blockchain+health+IP/27219083.html</link>
   <description>&lt;p&gt;DataMEDS AI, Inc. (NASDAQ: MEDS) announced it has entered into an amended and restated non-binding letter of intent dated October 19, 2026, to license and acquire intellectual property from several parties, including Datavault AI Inc. (NASDAQ: DVLT), Data Health Partners subsidiary REBOOT Health AI, EOS Technology Holdings, Scilex Holding Company (NASDAQ: SCLX), and HealthBridge Advisors.&lt;/p&gt;&lt;p&gt;The agreement supersedes a prior letter of intent dated July 29, 2026, which expired on September 30, 2026. The transaction is expected to close in the fourth quarter of 2026, pending execution of definitive agreements, due diligence, a fairness opinion, and Nasdaq requirements. A majority of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/DataMEDS+AI+signs+amended+LOI+to+acquire+drone+and+blockchain+health+IP/27219083.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:41:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI signs amended LOI to acquire drone and blockchain health IP</title>
   <link>http://www.streetinsider.com/Corporate+News/DataMEDS+AI+signs+amended+LOI+to+acquire+drone+and+blockchain+health+IP/27219083.html</link>
   <description>&lt;p&gt;DataMEDS AI, Inc. (NASDAQ: MEDS) announced it has entered into an amended and restated non-binding letter of intent dated October 19, 2026, to license and acquire intellectual property from several parties, including Datavault AI Inc. (NASDAQ: DVLT), Data Health Partners subsidiary REBOOT Health AI, EOS Technology Holdings, Scilex Holding Company (NASDAQ: SCLX), and HealthBridge Advisors.&lt;/p&gt;&lt;p&gt;The agreement supersedes a prior letter of intent dated July 29, 2026, which expired on September 30, 2026. The transaction is expected to close in the fourth quarter of 2026, pending execution of definitive agreements, due diligence, a fairness opinion, and Nasdaq requirements. A majority of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/DataMEDS+AI+signs+amended+LOI+to+acquire+drone+and+blockchain+health+IP/27219083.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:41:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI signs amended LOI to acquire drone and blockchain health IP</title>
   <link>http://www.streetinsider.com/Corporate+News/DataMEDS+AI+signs+amended+LOI+to+acquire+drone+and+blockchain+health+IP/27219083.html</link>
   <description>&lt;p&gt;DataMEDS AI, Inc. (NASDAQ: MEDS) announced it has entered into an amended and restated non-binding letter of intent dated October 19, 2026, to license and acquire intellectual property from several parties, including Datavault AI Inc. (NASDAQ: DVLT), Data Health Partners subsidiary REBOOT Health AI, EOS Technology Holdings, Scilex Holding Company (NASDAQ: SCLX), and HealthBridge Advisors.&lt;/p&gt;&lt;p&gt;The agreement supersedes a prior letter of intent dated July 29, 2026, which expired on September 30, 2026. The transaction is expected to close in the fourth quarter of 2026, pending execution of definitive agreements, due diligence, a fairness opinion, and Nasdaq requirements. A majority of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/DataMEDS+AI+signs+amended+LOI+to+acquire+drone+and+blockchain+health+IP/27219083.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:41:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / October 22, 2026 / &lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skum&quot;&gt;&lt;u&gt;DataMEDS AI, Inc.&lt;/u&gt;&lt;/a&gt; (&quot;DataMeds SI,&quot; &quot;DataMEDS&quot; or the &quot;Company&quot;) (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx&lt;sup&gt;™&lt;/sup&gt; artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that it has entered into an amended and restated non-binding letter of intent dated October 19, 2026 (&quot;LOI&quot;) with &lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skun&quot;&gt;&lt;u&gt;Datavault AI Inc&lt;/u&gt;&lt;/a&gt;. (&quot;Datavault AI&quot;) (NASDAQ:DVLT), Data Health Partners, Inc.'s (&quot;DHP&quot;) wholly-owned subsidiary REBOOT Health AI, Inc., EOS Technology Holdings, Inc. (&quot;EOS&quot;), Scilex</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / October 22, 2026 / &lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skum&quot;&gt;&lt;u&gt;DataMEDS AI, Inc.&lt;/u&gt;&lt;/a&gt; (&quot;DataMeds SI,&quot; &quot;DataMEDS&quot; or the &quot;Company&quot;) (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx&lt;sup&gt;™&lt;/sup&gt; artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that it has entered into an amended and restated non-binding letter of intent dated October 19, 2026 (&quot;LOI&quot;) with &lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skun&quot;&gt;&lt;u&gt;Datavault AI Inc&lt;/u&gt;&lt;/a&gt;. (&quot;Datavault AI&quot;) (NASDAQ:DVLT), Data Health Partners, Inc.'s (&quot;DHP&quot;) wholly-owned subsidiary REBOOT Health AI, Inc., EOS Technology Holdings, Inc. (&quot;EOS&quot;), Scilex</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / October 22, 2026 / &lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skum&quot;&gt;&lt;u&gt;DataMEDS AI, Inc.&lt;/u&gt;&lt;/a&gt; (&quot;DataMeds SI,&quot; &quot;DataMEDS&quot; or the &quot;Company&quot;) (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx&lt;sup&gt;™&lt;/sup&gt; artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that it has entered into an amended and restated non-binding letter of intent dated October 19, 2026 (&quot;LOI&quot;) with &lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skun&quot;&gt;&lt;u&gt;Datavault AI Inc&lt;/u&gt;&lt;/a&gt;. (&quot;Datavault AI&quot;) (NASDAQ:DVLT), Data Health Partners, Inc.'s (&quot;DHP&quot;) wholly-owned subsidiary REBOOT Health AI, Inc., EOS Technology Holdings, Inc. (&quot;EOS&quot;), Scilex</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / October 22, 2026 / &lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skum&quot;&gt;&lt;u&gt;DataMEDS AI, Inc.&lt;/u&gt;&lt;/a&gt; (&quot;DataMeds SI,&quot; &quot;DataMEDS&quot; or the &quot;Company&quot;) (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx&lt;sup&gt;™&lt;/sup&gt; artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that it has entered into an amended and restated non-binding letter of intent dated October 19, 2026 (&quot;LOI&quot;) with &lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skun&quot;&gt;&lt;u&gt;Datavault AI Inc&lt;/u&gt;&lt;/a&gt;. (&quot;Datavault AI&quot;) (NASDAQ:DVLT), Data Health Partners, Inc.'s (&quot;DHP&quot;) wholly-owned subsidiary REBOOT Health AI, Inc., EOS Technology Holdings, Inc. (&quot;EOS&quot;), Scilex</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / October 22, 2026 / &lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skum&quot;&gt;&lt;u&gt;DataMEDS AI, Inc.&lt;/u&gt;&lt;/a&gt; (&quot;DataMeds SI,&quot; &quot;DataMEDS&quot; or the &quot;Company&quot;) (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx&lt;sup&gt;™&lt;/sup&gt; artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that it has entered into an amended and restated non-binding letter of intent dated October 19, 2026 (&quot;LOI&quot;) with &lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skun&quot;&gt;&lt;u&gt;Datavault AI Inc&lt;/u&gt;&lt;/a&gt;. (&quot;Datavault AI&quot;) (NASDAQ:DVLT), Data Health Partners, Inc.'s (&quot;DHP&quot;) wholly-owned subsidiary REBOOT Health AI, Inc., EOS Technology Holdings, Inc. (&quot;EOS&quot;), Scilex</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;TAMPA, FL / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / October 22, 2026 / &lt;/strong&gt;&lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skum&quot;&gt;&lt;u&gt;DataMEDS AI, Inc.&lt;/u&gt;&lt;/a&gt; (&quot;DataMeds SI,&quot; &quot;DataMEDS&quot; or the &quot;Company&quot;) (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx&lt;sup&gt;™&lt;/sup&gt; artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that it has entered into an amended and restated non-binding letter of intent dated October 19, 2026 (&quot;LOI&quot;) with &lt;a rel=&quot;nofollow&quot; href=&quot;https://pr.report/skun&quot;&gt;&lt;u&gt;Datavault AI Inc&lt;/u&gt;&lt;/a&gt;. (&quot;Datavault AI&quot;) (NASDAQ:DVLT), Data Health Partners, Inc.'s (&quot;DHP&quot;) wholly-owned subsidiary REBOOT Health AI, Inc., EOS Technology Holdings, Inc. (&quot;EOS&quot;), Scilex</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/DataMEDS+AI+Enters+Into+Amended+and+Restated+LOI+to+License+and+Acquire+IP+that+Enables+Goal-Driven+Prescription+Drug+Telehealth%2C+Medical+Drones+and+Healthcare+Blockchain+Technologies/27219076.html</guid>
   <pubDate>Thu, 22 Oct 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MEDS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>Form  8-K        Scilex Holding Co         For: Sep 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Scilex+Holding+Co+++++++++For%3A+Sep+25/27122482.html</link>
   <description>si-local-file:///var/storage/secattach/20260929/27122482.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Scilex+Holding+Co+++++++++For%3A+Sep+25/27122482.html</guid>
   <pubDate>Tue, 29 Sep 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>Form  10-Q       Scilex Holding Co         For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Scilex+Holding+Co+++++++++For%3A+Jun+30/26931987.html</link>
   <description>
&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;http://archive.fast-edgar.com/20260814/AF2BA22FZZ2RN9Z222JH2ZYPMVFCZZ22N282&quot;&gt;http://archive.fast-edgar.com/20260814/AF2BA22FZZ2RN9Z222JH2ZYPMVFCZZ22N282&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;
Filed on: August 14, 2026
&lt;/p&gt;
</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Scilex+Holding+Co+++++++++For%3A+Jun+30/26931987.html</guid>
   <pubDate>Fri, 14 Aug 2026 16:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>Form  10-Q       Scilex Holding Co         For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Scilex+Holding+Co+++++++++For%3A+Jun+30/26931987.html</link>
   <description>
&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;http://archive.fast-edgar.com/20260814/AF2BA22FZZ2RN9Z222JH2ZYPMVFCZZ22N282&quot;&gt;http://archive.fast-edgar.com/20260814/AF2BA22FZZ2RN9Z222JH2ZYPMVFCZZ22N282&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;
Filed on: August 14, 2026
&lt;/p&gt;
</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Scilex+Holding+Co+++++++++For%3A+Jun+30/26931987.html</guid>
   <pubDate>Fri, 14 Aug 2026 16:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
  <item>
   <title>JP 3E Holdings adds three directors with life sciences backgrounds</title>
   <link>http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</link>
   <description>

&lt;p&gt;JP 3E Holdings, Inc. (OTC Markets: JPTE) announced the appointment of Henry Ji, Ph.D., Stephen Ma and Jaedong Yoon to its board of directors, effective August 13, 2026, according to a company press release.&lt;/p&gt;

&lt;p&gt;Henry Ji currently serves as Executive Chairperson, President and Chief Executive Officer of Scilex Holding Company (Nasdaq: SCLX). He previously co-founded Sorrento Therapeutics, Inc. and holds a Ph.D. in animal physiology from the University of Minnesota.&lt;/p&gt;

&lt;p&gt;Stephen Ma serves as Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Director of Scilex Holding Company. He previously held finance roles at Anwita Biosciences, Ardelyx, Inc. and Globavir Biosciences, Inc.,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/JP+3E+Holdings+adds+three+directors+with+life+sciences+backgrounds/26926586.html</guid>
   <pubDate>Fri, 14 Aug 2026 10:39:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03788868</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.04661574</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19420966</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214290</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DVLT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JPTE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00982709</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04721080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04892715</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22200071</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31794194</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.38595835</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.48401414</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49500138</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SCLX</category>
   	  </item>
 </channel>
</rss>
